According to a February 2022 report by Research and Markets, the clinical trials market in India was estimated to be val...
Biosyngen, an immuno-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma tre...
Cyteph, a spin-out biotechnology company from QIMR Berghofer Medical Research Institute in Australia, has been awa...
Singapore-based startup Hummingbird Bioscience has entered into a clinical trial collaboration and supply agreement with...
How do you define the essentials of a decentralised approach in the current drug discovery landscape? It is essential t...
Omi Medical Center, a part of the Seikoukai Social Medical Corporation and one of Japan's leading institu...
In collaboration with US-based Kiora Pharmaceuticals, Inc. and The Royal Adelaide Hospital, leading Australian Contract ...
Australian biotech firm Vaxxas has announced the initiation of a Phase I clinical trial with the first inactivated ...
South Korean firm Wellmarker Bio (WMBIO) has entered a clinical trial collaboration and supply agreement with Merck (kno...
Australia's CardieX Limited, a global health technology company focused on patient-centric healthcare research and impro...
P3 Research, a leading New Zealand (NZ) clinical trials site network with seven locations across New Zealand, has t...
New Zealand's leading health agencies will explore system-level changes to improve benefits from clinical trials, based ...
Singapore-based startup Oncoshot and internationally recognised contract research organisation (CRO) Novotech have begun...
China-based startup Jacobio has entered into a clinical trial collaboration agreement with Merck on clinical study of co...
A multi-national, investigator-initiated and industry-backed clinical trial has been launched to test the efficacy of a ...
The Asia Pacific (APAC) region has taken in the lead in cell and gene clinical trials, accounting for the largest share ...
Australia-based Alterity Therapeutics has announced that the company’s Phase 2 clinical trial of ATH434 for ...
Hematogenix, the first central oncology laboratory for clinical trials in Malaysia has been officiated by the Minister o...
Crux Biolabs, a leading Australian laboratory for vaccines, immunotherapies, immuno-oncology and infectious diseases, ha...
Japan-based Aculys Pharma has entered into a contract with SUSMED, Inc., a company that promotes digital medicine, to co...
Singapore-based AUM Biosciences has entered into a clinical trial collaboration and supply agreement with Roche to evalu...
Genome and Company, a leading global microbiome anti-cancer drug development company in Korea, has entered into a first ...
Shanghai Public Health Clinical Centre and Cheng Kung University's Department of Microbiology and Immunology have joined...
ObvioHealth, a global Virtual Research Organization (VRO), is set to launch a first-of-its-kind clinical trial in A...
Futura Medical, a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transde...
